Biocon Biologics secures strong market coverage for Yesintek in US
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
Alembic Pharmaceuticals commissions new facility at Pithampur
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
The products will be manufactured in Goa India and marketed & distributed in Australian markets
Subscribe To Our Newsletter & Stay Updated